C-reactive protein polygenic risk is associated with obesity-related traits in schizophrenia spectrum disorders
Frontiers in Psychiatry · 14.07.2026 · 17
DOI: 10.3389/fpsyt.2026.1873942 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Psychiatry, online erschienen am 14.07.2026. Verfasst von Chenxu Zhao und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Epidemiology, University Medical Center Groningen, University of Groningen, Groningen, Netherlands. Die Arbeit nennt 88 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Patients with schizophrenia spectrum disorders (SSDs) are at increased risk of cardiometabolic dysregulations, which substantially contribute to cardiovascular morbidity and reduced life expectancy. Chronic low-grade inflammation is a key factor in the development of cardiometabolic outcomes. Polygenic risk scores (PRS) for inflammatory biomarkers like for C-reactive protein (CRP) and interleukin 6 (IL-6) may help clarify the genetic contribution to this risk, yet evidence in SSDs populations remains limited.
Methods
We investigated the associations of PRSes for CRP and IL6 with cardiometabolic outcomes in 671 patients with SSDs from the longitudinal Dutch Genetic Risk and Outcome in Psychosis (GROUP) study. Seven PRS CRP and seven PRS IL-6 were constructed using clumping and threshold method at seven P -value thresholds ( P t_x ) based on large, independent genome-wide association studies. We examined 11 cardiometabolic outcomes measured at three years after diagnosis, including body mass index (BMI), waist circumference (WC), lipid levels, blood pressures, glycaemic markers, and a metabolic composite score. Linear regression models adjusted for age, sex, and population substructure tested the associations between PRSes, with multiple testing correction and bootstrapping for validation. Regression coefficients (β P-threshold ) and 95% confidence intervals and unadjusted R 2 (variance explained) were reported. Sensitivity analyses were conducted by further adjusting for smoking and antipsychotic medication use.
Results
Higher standardized PRS CRP was significantly associated with increased BMI (β Pt_0.5 = 0.64, 95%CI=0.21-1.02, P bootstapping = 0.003) and WC (β Pt_0.5 = 2.25, 1.00-3.53, P bootstapping < 0.001), explaining up to 1.85% variance in BMI, and 2.52% in WC. Nominal associations were also observed between PRS CRP and triglycerides (TG) levels (β Pt_0.2 = 0.13, 0.01-0.26, P bootstapping = 0.036), and metabolic composite score (β Pt_0.2 = 0.14, 0.04-0.24, P bootstapping = 0.006), and between PRS IL-6 and HbA1c level (β Pt_5e06 =-0.66, -1.26 to -0.05, P bootstapping = 0.033); however these associations did not remain significant after correction for multiple testing.
Conclusions
Higher genetic susceptibility for low grade inflammation as captured by PRS CRP is modestly but robustly associated with increased levels of obesity-related traits in SSDs independent from antipsychotics use. These results support CRP-related genetics pathways as potential contributors to risk of cardiometabolic vulnerability in SSDs and may inform genetic-based personalized risk stratification and prevention strategies in SSDs patients.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Epidemiology, University Medical Center Groningen, University of Groningen, Groningen, Netherlands.
- Department of Psychiatry and Neuropsychology, Maastricht University Medical Center, School for Mental Health and Neuroscience, Maastricht, Netherlands.
- Brain Centre Rudolf Magnus, Department of Psychiatry, University Medical Center Utrecht, Utrecht University, Utrecht, Netherlands.
- Altrecht, General Mental Health Care, Utrecht, Netherlands.
- Department of Psychiatry, Amsterdam UMC, University of Amsterdam, Amsterdam, Netherlands.
- Arkin Institute for Mental Health, Amsterdam, Netherlands.
Zitieren
APA
Zhao, C., Naderi, E., Habtewold, T. D., van Amelsvoort, T., Cahn, W., de Haan, L., van der Pluijm, M., Simons, C. J. P., van Os, J., Veling, W., Bruggeman, R., & Alizadeh, B. Z. (2026). C-reactive protein polygenic risk is associated with obesity-related traits in schizophrenia spectrum disorders. Frontiers in Psychiatry, 17. https://doi.org/10.3389/fpsyt.2026.1873942
Vancouver
Zhao C, Naderi E, Habtewold TD, van Amelsvoort T, Cahn W, de Haan L, et al. C-reactive protein polygenic risk is associated with obesity-related traits in schizophrenia spectrum disorders. Frontiers in Psychiatry. 2026;17. doi:10.3389/fpsyt.2026.1873942
BibTeX
@article{Zhao2026,
author = {Zhao, Chenxu and Naderi, Elnaz and Habtewold, Tesfa Dejenie and van Amelsvoort, Therese and Cahn, Wiepke and de Haan, Lieuwe and van der Pluijm, Marieke and Simons, Claudia J P and van Os, Jim and Veling, Wim and Bruggeman, Richard and Alizadeh, Behrooz Z},
title = {C-reactive protein polygenic risk is associated with obesity-related traits in schizophrenia spectrum disorders},
journal = {Frontiers in Psychiatry},
year = {2026},
volume = {17},
doi = {10.3389/fpsyt.2026.1873942}
}
EUVIMED